Fiera Capital (Canada)’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,356	Closed	-$605K	–	760
2018 Q3	$605K	Sell	4,356 -69	-2%	-$8.66K	﹤0.01%	539
2018 Q2	$549K	Sell	4,425 -35	-0.8%	-$4.09K	﹤0.01%	535
2018 Q1	$497K	Sell	4,460 -3,125	-41%	-$374K	﹤0.01%	509
2017 Q4	$907K	Sell	7,585 -62,505	-89%	-$7.61M	﹤0.01%	445
2017 Q3	$9.83M	Buy	+70,090	New	+$9.52M	0.05%	238
2015 Q3	–	Sell	-1,500	Closed	-$271	–	581
2015 Q2	$271	Buy	+1,500	New	+$259K	﹤0.01%	499
2014 Q4	–	Sell	-1,300	Closed	-$216K	–	462
2014 Q3	$216K	Sell	1,300 -500	-28%	-$82.1K	﹤0.01%	441
2014 Q2	$281K	Sell	1,800 -6,100	-77%	-$963K	﹤0.01%	469
2014 Q1	$1.2M	Sell	7,900 -4,000	-34%	-$636K	0.01%	413
2013 Q4	$1.58M	Buy	11,900 +10,000	+526%	+$1.2M	0.01%	382
2013 Q3	$221K	Buy	+1,900	New	+$208K	﹤0.01%	343